Literature DB >> 24618614

Desmoplastic melanoma with sarcomatoid dedifferentiation.

Maija Kiuru1, Gregory McDermott, Michael Berger, Allan C Halpern, Klaus J Busam.   

Abstract

Desmoplastic melanoma (DM) is a variant of melanoma, which typically affects chronically sun-damaged skin of elderly patients. Pure DM displays a low density of fusiform melanocytes in a collagen-rich matrix. In mixed DM, tumor cell density is higher, and parts of the tumor lack abundant stromal fibrosis. Both pure and mixed DMs usually express S100 protein homogenously. We report herein an unusual biphenotypic tumor characterized by the association of a pure DM with an undifferentiated solid spindle cell nodule. It occurred on the scalp of a 66-year-old man. A biopsy of the undifferentiated spindle cell nodule was initially interpreted at a commercial laboratory as atypical fibroxanthoma. The pure DM was seen only in the excisional specimen. All cells of the pure DM stained for S100 protein and SOX10. The adjacent solid sarcomatoid spindle cell nodule lacked expression of S100 protein, SOX10, as well as melan-A, gp100, and microphthalmia-associated transcription factor in >95% of its tumor cells. Although focal expression of melanocyte differentiation antigens in the solid tumor component made us favor a combined DM with sarcomatoid dedifferentiation, we also considered the possibility of a collision scenario, that is, a pleomorphic dermal sarcoma incidentally colliding with a DM. To further assess a possible relationship of the sarcomatoid nodule with the DM, we performed next-generation sequencing analysis on each component separately. The analysis revealed shared chromosomal copy number changes and a high number of common mutations, thereby supporting the concept of a DM with a dedifferentiated sarcomatoid component. An interesting finding is the presence of mutations of the neurofibromin 1 (NF1) gene in both tumor components.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24618614      PMCID: PMC4568751          DOI: 10.1097/PAS.0000000000000201

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  33 in total

1.  Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.

Authors:  B C Bastian; U Wesselmann; D Pinkel; P E Leboit
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.

Authors:  Ajay K Gopal; Brad S Kahl; Sven de Vos; Nina D Wagner-Johnston; Stephen J Schuster; Wojciech J Jurczak; Ian W Flinn; Christopher R Flowers; Peter Martin; Andreas Viardot; Kristie A Blum; Andre H Goy; Andrew J Davies; Pier Luigi Zinzani; Martin Dreyling; Dave Johnson; Langdon L Miller; Leanne Holes; Daniel Li; Roger D Dansey; Wayne R Godfrey; Gilles A Salles
Journal:  N Engl J Med       Date:  2014-01-22       Impact factor: 91.245

3.  Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma).

Authors:  J Conley; R Lattes; W Orr
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

Review 4.  Cutaneous desmoplastic melanoma.

Authors:  Klaus J Busam
Journal:  Adv Anat Pathol       Date:  2005-03       Impact factor: 3.875

5.  Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

Authors:  B C Bastian; P E LeBoit; D Pinkel
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.

Authors:  R Gutzmer; R A Herbst; S Mommert; P Kiehl; F Matiaske; A Rütten; A Kapp; J Weiss
Journal:  Hum Genet       Date:  2000-10       Impact factor: 4.132

7.  Absence of V599E BRAF mutations in desmoplastic melanomas.

Authors:  Jon M Davison; Eli Rosenbaum; Terry L Barrett; David Goldenberg; Mohammad O Hoque; David Sidransky; William H Westra
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

8.  Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors.

Authors:  Klaus J Busam; Urvi Mujumdar; Amanda J Hummer; Jennifer Nobrega; William G Hawkins; Daniel G Coit; Mary S Brady
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

9.  Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.

Authors:  Julia Reifenberger; Christiane B Knobbe; Astrid A Sterzinger; Britta Blaschke; Klaus W Schulte; Thomas Ruzicka; Guido Reifenberger
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  10 in total

Review 1.  The NF1 gene in tumor syndromes and melanoma.

Authors:  Maija Kiuru; Klaus J Busam
Journal:  Lab Invest       Date:  2017-01-09       Impact factor: 5.662

2.  Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.

Authors:  Sophie Le Guellec; Nicolas Macagno; Valérie Velasco; Laurence Lamant; Marick Lae; Thomas Filleron; Nausicaa Malissen; Elisabeth Cassagnau; Philippe Terrier; Christine Chevreau; Dominique Ranchere-Vince; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

3.  NF1 Mutations Are Common in Desmoplastic Melanoma.

Authors:  Thomas Wiesner; Maija Kiuru; Sasinya N Scott; Maria Arcila; Allan C Halpern; Travis Hollmann; Michael F Berger; Klaus J Busam
Journal:  Am J Surg Pathol       Date:  2015-10       Impact factor: 6.394

4.  New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.

Authors:  Niels J Rupp; Markus Rechsteiner; Sandra N Freiberger; Daniela Lenggenhager; Mirjana Urosevic; Irene A Burger; Elisabeth J Rushing; Daniela Mihic-Probst
Journal:  Virchows Arch       Date:  2018-05-21       Impact factor: 4.064

5.  Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.

Authors:  Stephan W Jahn; Karl Kashofer; Iris Halbwedl; Gerlinde Winter; Laila El-Shabrawi-Caelen; Thomas Mentzel; Gerald Hoefler; Bernadette Liegl-Atzwanger
Journal:  Mod Pathol       Date:  2015-03-13       Impact factor: 7.842

6.  Distinguishing Neurofibroma From Desmoplastic Melanoma: The Value of p53.

Authors:  Ashley Elsensohn; Jessica Shiu; Narina Grove; Anna-Marie Hosking; Ronald Barr; Sébastien de Feraudy
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

7.  Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.

Authors:  Carlos N Prieto-Granada; Thomas Wiesner; Jane L Messina; Achim A Jungbluth; Ping Chi; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

Review 8.  Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.

Authors:  Thomas Brenn
Journal:  Head Neck Pathol       Date:  2020-01-16

9.  Melanoma Mimicking Malignant Peripheral Nerve Sheath Tumor with Spread to the Cerebellopontine Angle: Utility of Next-Generation Sequencing in Diagnosis.

Authors:  Katie Fox Hanson; Paul Birinyi; Ronald Walker; Constantine Raptis; Rebecca Chernock; Jeroen Coppens; Katherine E Schwetye
Journal:  Case Rep Pathol       Date:  2018-06-28

10.  The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma.

Authors:  Ingrid Ferreira; Alastair Droop; Olivia Edwards; Kim Wong; Victoria Harle; Omar Habeeb; Deepa Gharpuray-Pandit; Joseph Houghton; Katharina Wiedemeyer; Thomas Mentzel; Steven D Billings; Jennifer S Ko; Laszlo Füzesi; Kathleen Mulholland; Ivana Kuzmic Prusac; Bernadette Liegl-Atzwanger; Nicolas de Saint Aubain; Helen Caldwell; Laura Riva; Louise van der Weyden; Mark J Arends; Thomas Brenn; David J Adams
Journal:  Mod Pathol       Date:  2021-06-21       Impact factor: 7.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.